Description

Lefno Coated Tablets 20 mg. №30

Ingredients:

Each coated tablet contains 20 mg of Leflunomide.

Dosage:

The recommended dosage is one 20 mg tablet once daily.

Indications:

Lefno tablets are indicated for the treatment of rheumatoid arthritis to reduce signs and symptoms and to inhibit structural damage.

Contraindications:

Do not use Lefno tablets if you are pregnant, breastfeeding, or allergic to leflunomide.

Directions:

Swallow the tablet whole with water, with or without food, at the same time each day.

Scientific Evidence:

Leflunomide, the active ingredient in Lefno tablets, has been extensively studied for its efficacy in treating rheumatoid arthritis. Research published in the Journal of Rheumatology demonstrated that leflunomide significantly improved disease activity scores and slowed radiographic progression in patients with rheumatoid arthritis.

Additional Information:

Lefno tablets work by inhibiting pyrimidine synthesis, leading to anti-inflammatory and immunomodulatory effects. Clinical trials have shown that Lefno is comparable in efficacy to other disease-modifying antirheumatic drugs but with a more favorable side effect profile.

It is important to monitor liver function tests regularly while taking Lefno tablets due to the potential risk of hepatotoxicity. Consult your healthcare provider for personalized advice and monitoring.